RENOVORX, INC.

Profile

Company Names

RENOVORX, INC.

Addresses

2570 W EL CAMINO REAL, SUITE 320, MOUNTAIN VIEW, CA 94040

4546 EL CAMINO REAL, SUITE B1, LOS ALTOS, CA 94022

4546 EL CAMINO REAL, SUITE 203, LOS ALTOS, CA 94022

4546 EL CAMINO REAL, SUITE 282, LOS ALTOS, CA 94022

333 W. SANTA CLARA STREET, SUITE 900, SAN JOSE, CA 95110

Phone Numbers

650-284-4433
408-800-2649

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$39,457,954.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2026-03-20 
$9,999,929.00 
$10,000,000.00 
$71.00 
Equity 
6
2024-04-11 
$11,136,557.00 
$15,000,000.00 
$3,863,443.00 
Equity 
5
2024-01-26 
$6,111,695.00 
$15,000,000.00 
$8,888,305.00 
Equity 
4
2018-04-18 
$8,309,774.00 
$13,744,992.00 
$5,435,218.00 
Equity 
3
2015-12-07 
$2,099,999.00 
$2,099,999.00 
$0.00 
Equity 
2
2013-12-20 
$1,140,000.00 
$1,150,000.00 
$10,000.00 
Equity 
1
2013-01-23 
$660,000.00 
$698,625.00 
$38,625.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAMTIN 
 
AGAH 
EXECUTIVE OFFICER, DIRECTOR
RENOVORX, INC.
RAMTIN 
 
AGAH, M.D. 
EXECUTIVE OFFICER, DIRECTOR
RENOVORX, INC.
SHAUN 
R. 
BAGAI 
EXECUTIVE OFFICER, DIRECTOR
RENOVORX, INC.
JOOST 
 
DE SCHUTTER 
EXECUTIVE OFFICER
RENOVORX, INC.
LEESA 
 
GENTRY 
EXECUTIVE OFFICER
RENOVORX, INC.
KLAUS 
 
HAMBUECHEN 
DIRECTOR
RENOVORX, INC.
KLAUS 
W. 
HAMBUECHEN 
DIRECTOR
RENOVORX, INC.
RON 
 
KOCAK 
EXECUTIVE OFFICER
RENOVORX, INC.
RONALD 
B. 
KOCAK 
EXECUTIVE OFFICER
RENOVORX, INC.
KIRSTEN 
ANGELA 
MACFARLANE 
DIRECTOR
PERCEIVE BIOTHERAPEUTICS, INC.   |  RENOVORX, INC.
LAURENCE 
J. 
MARTON 
DIRECTOR
RENOVORX, INC.   |  MATTERNET, INC.
LAURENCE 
J. 
MARTON, M.D. 
DIRECTOR
RENOVORX, INC.
KAMRAN 
 
NAJMABADI 
EXECUTIVE OFFICER
RENOVORX, INC.
ANGELA 
GILL 
NELMS 
EXECUTIVE OFFICER
RENOVORX, INC.
FRANK 
 
RAHMANI 
EXECUTIVE OFFICER
SYNTHESYS RESEARCH INC   |  RENOVORX, INC.   |  MISFIT WEARABLES CORP   |  MISFIT, INC.
UNA 
S. 
RYAN 
DIRECTOR
RENOVORX, INC.
UNA 
S. 
RYAN, PH.D. 
DIRECTOR
RENOVORX, INC.
UNA 
S, 
RYAN, PHD 
DIRECTOR
RENOVORX, INC.
ROBERT 
 
SPIEGEL 
DIRECTOR
FACE2FACE PARTNERS I, LLC   |  PRE-IPO OPPORTUNITIES FUND LLC   |  EDGE THERAPEUTICS, INC.   |  NEXIMMUNE, INC.   |  ACUITY OPPORTUNITIES FUND I LLC   |  PINES AT WOODCREEK INVESTOR LLC   |  ACUITY DATAMINR LLC   |  ACUITY DATASTAX LLC   |  ACUITY VARO BANK LLC   |  ACUITY TANIUM LLC   |  ACUITY TURO LLC   |  ACUITY EPIRUS LLC   |  ACUITY SPV VII LLC   |  AYALA PHARMACEUTICALS, INC.   |  RENOVORX, INC.   |  CYCLACEL PHARMACEUTICALS, INC.   |  DAWSON FOREST INVESTORS LLC
ROBERT 
J. 
SPIEGEL 
DIRECTOR
TALON THERAPEUTICS, INC.   |  RENOVORX, INC.
MARK 
 
VOLL 
EXECUTIVE OFFICER
RENOVORX, INC.
MARTA 
GAIA 
ZANCHI, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
RENOVORX, INC.
MARTA 
GAIA 
ZANCHI, PHD 
EXECUTIVE OFFICER, DIRECTOR
RENOVORX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2026-03-20 
2024-04-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-04-11 
2024-02-09
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-01-26 
2018-06-19
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-18 
2016-01-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-07 
2013-12-23
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-20 
2013-04-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
T.R. WINSTON + COMPANY, LLC
10571
NONE
NONE
NEWBRIDGE SECURITIES CORPORATION
104065
NONE
NONE
PAULSON INVESTMENT COMPANY LLC
5670